Cornell Center for Tech., Enterprise, & Commerc.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Cornell Center for Tech., Enterprise, & Commerc.
Deals Shaping the Medical Industry (02/2011)
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions.
Avera Pharmaceuticals Inc.
Avera Pharmaceuticals Inc. is betting that there are enough promising neurological and psychiatric drugs gathering dust on the shelves of Big Pharma to support a substantial specialty business. It is starting out with a portfolio of neuromuscular blocker compounds acquired from GlaxoSmithKline PLC.
Cornell University
Cornell tries to turn Ithaca into a Cambridge-like hub of tech transfer.
Company Information
- Industry
- Academic and Research Institutions
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice